Natural Evolution of H5N1 Hemagglutinin Amino Acid Sequence and Its Implication on Human Adaptation and Antigenicity
Exclusively Licensed
Invention type: Technology
/
Case number: #16072
The present invention provides, among other things, technologies and methodologies for detection, treatment, and/or prevention of influenza transmission and/or infection. The present invention also provides technologies for monitoring influenza HA variants with particular degrees of susceptibility to mutation for human adaptation.
Researchers
Rahul Raman
/
Nathan Stebbins
/
Kannan Tharakaraman
/
Karthik Viswanathan
/
Ram Sasisekharan
Departments: Department of Biological Engineering, School of Engineering
Technology Areas: Diagnostics: Assays / Therapeutics: Nucleic Acids, Proteins & Antibodies
Impact Areas: Healthy Living
-
human adaptation of h5 influenza
Japan | Granted | 6,518,597 -
human adaptation of h5 influenza
Russian Federation | Granted | 2,708,447 -
human adaptation of h5 influenza
Germany | Granted | 2,953,967 -
human adaptation of h5 influenza
France | Granted | 2,953,967 -
human adaptation of h5 influenza
United Kingdom | Granted | 2,953,967 -
human adaptation of h5 influenza
Hong Kong | Granted | 1,215,257 -
human adaptation of h5 influenza
Canada | Granted | 2,898,633 -
human adaptation of h5 influenza
Australia | Granted | 2,014,214,754 -
human adaptation of h5 influenza
India | Granted | 534,921 -
human adaptation of h5 influenza
Hong Kong | Granted | 1,218,923 -
human adaptation of h5 influenza
Brazil | Granted | 0 -
human adaptation of h5 influenza
Singapore | Granted | 11,201,505,744 -
human adaptation of h5 influenza
China | Granted | 105,263,954 -
human adaptation of h5 influenza
European Patent Convention | Granted | 2,953,967
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.